Richard Dilorio - May 17, 2022 Form 4 Insider Report for InfuSystem Holdings, Inc (INFU)

Role
Chief Executive Officer, Director
Signature
/s/ Kevin Whitman, Attorney-in-Fact for Richard Dilorio
Stock symbol
INFU
Transactions as of
May 17, 2022
Transactions value $
$0
Form type
4
Date filed
5/17/2022, 05:10 PM
Previous filing
Jan 24, 2022
Next filing
May 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INFU Common Stock 242K May 17, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFU Stock Option (right to buy) Award $0 +60K $0.00 60K May 17, 2022 Common Stock 60K $8.58 Direct F2, F3
transaction INFU Restricted Stock Units Award $0 +40.9K $0.00 40.9K May 17, 2022 Common Stock 40.9K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This total includes an additional 1,858 shares acquired recently through the Company's Employee Stock Purchase Plan
F2 The stock option was issued with an exercise price equal to the Fair Value as defined by the 2021 Equity Plan, which is computed as the closing price of the Company's common stock reported on the NYSE American LLC on the date of grant.
F3 The option, representing the right to purchase a total of 59,984 shares of InfuSystem Holdings, Inc. common stock, vests in three equal annual installments beginning May 17, 2023.
F4 Restricted stock units convert into common stock on a one-for-one basis.
F5 These restricted stock units will cliff vest on May 17, 2025.